Chikungunya Vaccine Study in Previously Exposed Adults
Condition: Chikungunya Virus Infection Interventions: Biological: MV-CHIK; Other: Placebo Sponsors: Themis Bioscience GmbH; Walter Reed Army Institute of Research (WRAIR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2019 Category: Research Source Type: clinical trials
Phase 2 Study of a Chikungunya Vaccine in Previously Exposed Adults
Condition: Chikungunya Virus Infection Interventions: Biological: MV-CHIK; Other: Placebo Sponsors: Themis Bioscience GmbH; Walter Reed Army Institute of Research (WRAIR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2019 Category: Research Source Type: clinical trials
Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate
Saint-Herblain (France), December 21, 2018 - Valneva SE ("Valneva"), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, announced today that the U.S. Food and Drug Administration (FDA)... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 21, 2018 Category: Pharmaceuticals Source Type: clinical trials
Resistance Exercise Program on the Functionality of Individuals With Chikungunya Fever
Condition: Chikungunya Fever Intervention: Other: Resistance exercise Sponsor: Universidade Federal de Pernambuco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2018 Category: Research Source Type: clinical trials
